IBBIS collaborates with a wide array of global stakeholders—from industry and governments to academia and philanthropy—to develop practical tools and solutions for reducing risks at key points throughout the bioscience and biotechnology research and development lifecycle. IBBIS’ activities will complement the important work of the World Health Organization, the Biological Weapons Convention, and other regional and international organizations.
The international Common Mechanism for DNA synthesis screening can be used by DNA providers to screen DNA synthesis orders. It will be open source and operate efficiently to lower the cost and time barriers for DNA synthesis companies. Learn more about the Common Mechanism here.
Governments are key to safeguarding the life sciences, but many have struggled to keep pace with rapid technology advances. For example, 94 percent of countries reportedly have no national-level oversight measures, lead agency, or threat assessment for dual-use research. IBBIS develops practical solutions for governments to improve best practices for biosecurity and biosafety governance.
IBBIS helps all those involved in bioscience research and biotechnology development and use to identify vulnerabilities and manage risks throughout the research and development lifecycle – from funding and inception to realization and publication.
IBBIS brings together stakeholders in the biotech industry to build norms, policies, and tools to help safeguard bioscience and allow it to flourish. One such tool – the international Common Mechanism for DNA synthesis screening – can be used by DNA providers more effectively screen orders and customers to ensure DNA synthesis technology is not exploited.